Crossmark

Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment

Published Online: 2021-01-04

Published Print: 2021-05

Authors

Raven, Lisa M.

Guttman-Jones, Michelle

Muir, Christopher A. https://orcid.org/0000-0002-1430-0499
License Information

Text and Data Mining valid from 2021-01-04

Version of Record valid from 2021-01-04
More Information

Article History

Received: 26 September 2020

Accepted: 22 November 2020

First Online: 4 January 2021

Compliance with ethical standards

:

: L.M.R. declares that she has no conflict of interest, M.G.J. declares that she has no conflict of interest, C.A.M. declares that he has no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Document is current